研究单位：[1]Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology Wuhan,Hubei,China[2]Departments of Urology,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan,China
研究目的：
This study will evaluate the efficacy and safety of long term use of hCG alone or hCG plus hMG in the treatment of male patients with isolated hypogonadotropic hypogonadism (IHH). One third of the participants will receive hCG treatment alone and the other third of the participants will receive hCG treatment alone for six months, then the hMG will be added. And the last third of the participants will receive hCG and hMG treatment since the beginning of the treatment.
